XLMEDIA PLC Logo

XLMEDIA PLC

A former performance marketing company for the sports and gaming industries.

XLM | IL

Overview

Corporate Details

ISIN(s):
JE00BH6XDL31 (+2 more)
LEI:
2138008U4S6FBDHGWY81
Country:
Jersey
Address:
IFC 5, JE1 1ST St. Helier
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

XLMEDIA PLC was a global digital media company specializing in performance marketing for the sports and gaming industries. The company created and managed a portfolio of websites and digital content to attract engaged audiences, connecting them with advertisers and generating customer leads. Operating primarily in regulated markets in North America and Europe, its main verticals were sports media, sports betting, and gaming. In June 2025, the company's shares were delisted from the AIM stock exchange, and it initiated a liquidation process to settle liabilities and manage its remaining assets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-10 11:59
Delisting Announcement
Result of General Meeting and Cancellation
English 11.5 KB
2025-05-23 08:00
Delisting Announcement
Cancellation Update & Notice of General Meeting
English 20.0 KB
2025-05-14 13:39
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-05-14 08:00
Delisting Announcement
Suspension of Trading
English 10.2 KB
2025-05-13 13:36
Major Shareholding Notification
Holding(s) in Company
English 22.8 KB
2025-05-12 15:09
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-04-23 14:55
Regulatory News Service
Reminder of Tender Offer Application Deadline
English 15.0 KB
2025-04-22 14:42
Major Shareholding Notification
Holding(s) in Company
English 22.1 KB
2025-03-11 11:47
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-03-05 08:00
Major Shareholding Notification
Holding(s) in Company
English 52.5 KB
2025-02-28 16:49
Major Shareholding Notification
Holding(s) in Company
English 52.6 KB
2025-02-24 16:31
Director's Dealing
PDMR Dealings
English 57.4 KB
2025-02-21 08:00
Major Shareholding Notification
Holding(s) in Company
English 51.6 KB
2025-02-19 11:21
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-02-19 08:00
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB

Automate Your Workflow. Get a real-time feed of all XLMEDIA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for XLMEDIA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for XLMEDIA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.